ferrous gluconate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4491 299-29-6

Description:

MoleculeDescription

Synonyms:

  • sodium ferric gluconate complex
  • ferrous gluconate
  • iron gluconate
  • ferroglyconicum
  • glucoferron
iron important in this cpd; RN given refers to ferrous cpd
  • Molecular weight: 446.14
  • Formula: C12H22FeO14
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 265.04
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
0.20 g O

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Feb. 18, 1999 FDA SANOFI AVENTIS US

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Reversible airways obstruction 216.94 16.33 58 17589 1784 63469591
Vital capacity decreased 211.05 16.33 56 17591 1672 63469703
Sputum culture positive 198.50 16.33 56 17591 2111 63469264
Bronchial secretion retention 184.86 16.33 56 17591 2717 63468658
Presbyacusis 153.72 16.33 49 17598 2816 63468559
Pleural fibrosis 144.47 16.33 49 17598 3423 63467952
Pleural thickening 129.11 16.33 43 17604 2840 63468535
Deafness neurosensory 128.43 16.33 49 17598 4806 63466569
Eosinophil count increased 125.12 16.33 61 17586 10867 63460508
Blood magnesium increased 119.08 16.33 41 17606 2997 63468378
Oesophageal spasm 114.13 16.33 40 17607 3083 63468292
Upper-airway cough syndrome 113.78 16.33 58 17589 11360 63460015
Multiple allergies 106.17 16.33 59 17588 13743 63457632
Epigastric discomfort 106.12 16.33 47 17600 6733 63464642
Oesophageal pain 103.85 16.33 39 17608 3662 63467713
Smear cervix abnormal 101.06 16.33 36 17611 2910 63468465
Bone cyst 98.47 16.33 33 17614 2221 63469154
Obstructive airways disorder 86.51 16.33 60 17587 20639 63450736
Cyst 83.85 16.33 51 17596 14048 63457327
Osteosclerosis 80.93 16.33 33 17614 3855 63467520
Pulmonary mass 77.29 16.33 58 17589 22538 63448837
Urticaria 73.41 16.33 150 17497 165652 63305723
Osteopenia 70.39 16.33 52 17595 19733 63451642
Lymphoedema 68.77 16.33 42 17605 11650 63459725
Hyperhidrosis 68.47 16.33 114 17533 107722 63363653
Full blood count abnormal 62.05 16.33 59 17588 31658 63439717
Blood pressure decreased 60.20 16.33 82 17565 64940 63406435
Respiratory tract infection 59.02 16.33 65 17582 41418 63429957
Skin fissures 57.17 16.33 37 17610 11351 63460024
Skin lesion 56.05 16.33 55 17592 30666 63440709
Abdominal pain 55.15 16.33 193 17454 293263 63178112
Blood potassium increased 53.90 16.33 43 17604 18266 63453109
Deformity 53.88 16.33 36 17611 11648 63459727
Flushing 49.82 16.33 81 17566 75006 63396369
Hypotension 47.54 16.33 175 17472 272429 63198946
Allergic sinusitis 47.32 16.33 16 17631 1106 63470269
CFTR gene mutation 46.58 16.33 10 17637 116 63471259
Alopecia 44.64 16.33 19 17628 337517 63133858
Osteoarthritis 44.22 16.33 88 17559 95255 63376120
Dyspnoea 44.03 16.33 324 17323 660989 62810386
Sputum culture 43.78 16.33 11 17636 263 63471112
Endodontic procedure 43.12 16.33 20 17627 3187 63468188
Heart rate decreased 42.98 16.33 58 17589 45502 63425873
Discoloured vomit 42.69 16.33 14 17633 880 63470495
Myocardial infarction 42.54 16.33 89 17558 99804 63371571
Toothache 41.96 16.33 38 17609 19161 63452214
Dry eye 41.71 16.33 54 17593 40707 63430668
Occult blood 41.25 16.33 15 17632 1286 63470089
Localised infection 35.66 16.33 43 17604 30167 63441208
Sleep apnoea syndrome 35.27 16.33 42 17605 29091 63442284
Tooth disorder 34.76 16.33 41 17606 28116 63443259
Exostosis 34.49 16.33 33 17614 17829 63453546
Wound 34.28 16.33 3 17644 163260 63308115
Blood iron decreased 33.88 16.33 30 17617 14691 63456684
Blood pressure fluctuation 33.51 16.33 52 17595 46265 63425110
Tinnitus 31.56 16.33 44 17603 35584 63435791
Fluid retention 31.23 16.33 58 17589 59628 63411747
Renal impairment 31.15 16.33 73 17574 88282 63383093
Mite allergy 30.17 16.33 10 17637 650 63470725
Completed suicide 29.72 16.33 3 17644 145670 63325705
Cystitis 29.48 16.33 54 17593 54937 63416438
Internal haemorrhage 28.96 16.33 18 17629 5147 63466228
Vomiting 27.89 16.33 257 17390 559360 62912015
Synovitis 27.23 16.33 9 17638 186909 63284466
Pancreatitis relapsing 27.03 16.33 10 17637 900 63470475
Chest discomfort 26.65 16.33 79 17568 109890 63361485
Lip pruritus 26.64 16.33 10 17637 937 63470438
Infusion related reaction 26.16 16.33 136 17511 245385 63225990
Abdominal pain upper 26.03 16.33 120 17527 206324 63265051
Medication error 25.12 16.33 49 17598 52235 63419140
Agitation 23.99 16.33 52 17595 59705 63411670
Skin discolouration 22.66 16.33 39 17608 37789 63433586
Anaphylactic reaction 22.63 16.33 54 17593 66046 63405329
Skin depigmentation 22.59 16.33 9 17638 990 63470385
Anal incontinence 22.36 16.33 23 17624 13553 63457822
Choluria 21.97 16.33 6 17641 200 63471175
Bone hypertrophy 21.71 16.33 7 17640 417 63470958
Malaise 21.68 16.33 193 17454 415761 63055614
Loss of consciousness 21.52 16.33 77 17570 118044 63353331
Burning sensation 21.45 16.33 47 17600 54360 63417015
Therapeutic reaction time decreased 20.63 16.33 11 17636 2359 63469016
Toxicity to various agents 20.61 16.33 23 17624 247227 63224148
Blood creatinine increased 20.23 16.33 62 17585 87782 63383593
Product use in unapproved indication 19.36 16.33 13 17634 179067 63292308
Syncope 19.28 16.33 74 17573 117311 63354064
Depression 18.98 16.33 106 17541 196386 63274989
Pallor 18.95 16.33 32 17615 30536 63440839
Therapeutic response decreased 18.67 16.33 48 17599 61477 63409898
Sleep disorder 18.26 16.33 57 17590 81509 63389866
Therapeutic product effect incomplete 18.24 16.33 6 17641 125050 63346325
Sinusitis 17.90 16.33 22 17625 226631 63244744
Anxiety 17.58 16.33 112 17535 217429 63253946
Contusion 17.45 16.33 10 17637 150034 63321341
Cough 17.44 16.33 140 17507 292603 63178772
Cushingoid 17.00 16.33 16 17631 8469 63462906
Febrile neutropenia 16.73 16.33 6 17641 118443 63352932
Respiratory alkalosis 16.65 16.33 10 17637 2691 63468684
Headache 16.40 16.33 106 17541 633135 62838240

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Appendicolith 453.82 21.46 141 8491 8460 34939839
Appendicitis 378.73 21.46 141 8491 14666 34933633
Cardiogenic shock 305.08 21.46 143 8489 26475 34921824
Stress 302.15 21.46 148 8484 30199 34918100
Ascites 245.28 21.46 149 8483 46422 34901877
Abdominal distension 223.67 21.46 153 8479 58339 34889960
Ventricular fibrillation 207.75 21.46 105 8527 22849 34925450
Blood phosphorus increased 188.02 21.46 71 8561 7650 34940649
Multiple organ dysfunction syndrome 182.67 21.46 151 8481 76415 34871884
Hyponatraemia 174.56 21.46 152 8480 82539 34865760
General physical health deterioration 148.45 21.46 170 8462 128099 34820200
Abdominal pain 124.48 21.46 176 8456 163442 34784857
Constipation 123.39 21.46 160 8472 136822 34811477
Sepsis 114.78 21.46 171 8461 166390 34781909
Vitamin D deficiency 96.14 21.46 42 8590 6566 34941733
Dry mouth 94.51 21.46 70 8562 30095 34918204
Myasthenia gravis 84.67 21.46 39 8593 6901 34941398
Vomiting 78.52 21.46 182 8450 247439 34700860
Blood uric acid increased 78.23 21.46 41 8591 9583 34938716
C-reactive protein decreased 73.61 21.46 25 8607 1977 34946322
Drug intolerance 58.85 21.46 73 8559 59497 34888802
Nausea 58.38 21.46 200 8432 339708 34608591
Blood cholesterol increased 49.83 21.46 41 8591 20502 34927797
Drug therapy 48.93 21.46 16 8616 1125 34947174
Analgesic therapy 46.89 21.46 15 8617 983 34947316
Dental caries 44.64 21.46 22 8610 4517 34943782
Haematochezia 44.30 21.46 56 8576 46478 34901821
Gastrointestinal disorder 42.50 21.46 47 8585 33901 34914398
Sleep disorder therapy 42.47 21.46 14 8618 1009 34947290
Hyperphosphataemia 42.14 21.46 21 8611 4416 34943883
Incorrect route of product administration 38.89 21.46 31 8601 14814 34933485
Colitis 38.44 21.46 47 8585 37703 34910596
Condition aggravated 37.23 21.46 118 8514 192078 34756221
Blood pressure fluctuation 35.18 21.46 37 8595 25212 34923087
Drug hypersensitivity 34.40 21.46 67 8565 80462 34867837
Peripheral swelling 30.66 21.46 62 8570 76479 34871820
Somnolence 30.04 21.46 77 8555 111039 34837260
Hypophosphataemia 28.83 21.46 23 8609 11003 34937296
Diabetes mellitus inadequate control 26.79 21.46 24 8608 13440 34934859
Bacterial infection 25.56 21.46 26 8606 17037 34931262
Neuralgia 24.42 21.46 24 8608 15089 34933210
Toxicity to various agents 23.58 21.46 10 8622 200352 34747947
Withdrawal hypertension 22.82 21.46 6 8626 195 34948104
Drug interaction 22.54 21.46 14 8618 225932 34722367
Off label use 21.72 21.46 177 8455 419347 34528952

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Appendicolith 421.83 15.24 140 23970 8411 79711867
Appendicitis 301.10 15.24 140 23970 20654 79699624
Cardiogenic shock 216.58 15.24 143 23967 41771 79678507
Vital capacity decreased 189.81 15.24 53 24057 1763 79718515
Reversible airways obstruction 189.15 15.24 55 24055 2121 79718157
Stress 169.43 15.24 161 23949 79451 79640827
Ascites 168.84 15.24 157 23953 75405 79644873
Blood phosphorus increased 157.03 15.24 72 24038 10275 79710003
Ventricular fibrillation 153.06 15.24 104 24006 31822 79688456
Sputum culture positive 151.53 15.24 53 24057 3728 79716550
Abdominal pain 150.09 15.24 350 23760 389219 79331059
Bronchial secretion retention 147.29 15.24 53 24057 4051 79716227
Presbyacusis 136.95 15.24 45 24065 2615 79717663
Abdominal distension 132.73 15.24 172 23938 119478 79600800
Oesophageal spasm 117.93 15.24 43 24067 3413 79716865
Pleural fibrosis 117.21 15.24 45 24065 4122 79716156
Multiple organ dysfunction syndrome 112.28 15.24 159 23951 120087 79600191
Pleural thickening 108.85 15.24 39 24071 2943 79717335
Oesophageal pain 105.49 15.24 42 24068 4237 79716041
Smear cervix abnormal 103.36 15.24 36 24074 2500 79717778
Multiple allergies 102.45 15.24 54 24056 10406 79709872
Upper-airway cough syndrome 102.30 15.24 56 24054 11637 79708641
Blood magnesium increased 95.54 15.24 37 24073 3469 79716809
Deafness neurosensory 95.35 15.24 45 24065 6853 79713425
Vomiting 87.50 15.24 415 23695 665413 79054865
Eosinophil count increased 87.43 15.24 58 24052 17047 79703231
Epigastric discomfort 83.74 15.24 43 24067 7853 79712425
Bone cyst 82.22 15.24 33 24077 3400 79716878
Osteosclerosis 80.90 15.24 34 24076 3937 79716341
Obstructive airways disorder 77.32 15.24 69 24041 31390 79688888
Hyponatraemia 71.79 15.24 163 23947 177685 79542593
Lymphoedema 70.57 15.24 45 24065 12368 79707910
Blood uric acid increased 69.97 15.24 46 24064 13314 79706964
Cyst 68.50 15.24 46 24064 13794 79706484
Sepsis 64.13 15.24 203 23907 269225 79451053
Myasthenia gravis 62.38 15.24 39 24071 10360 79709918
Osteopenia 61.13 15.24 48 24062 18316 79701962
Full blood count abnormal 60.93 15.24 68 24042 40406 79679872
Pulmonary mass 60.34 15.24 58 24052 28976 79691302
Blood pressure fluctuation 60 15.24 87 24023 67058 79653220
Completed suicide 55.91 15.24 5 24105 245762 79474516
Deformity 55.05 15.24 35 24075 9570 79710708
Nausea 54.07 15.24 482 23628 956714 78763564
Urticaria 53.99 15.24 150 23960 185051 79535227
Toxicity to various agents 52.82 15.24 31 24079 421509 79298769
Dry eye 52.11 15.24 60 24050 36871 79683407
C-reactive protein decreased 51.55 15.24 22 24088 2646 79717632
Vitamin D deficiency 51.18 15.24 39 24071 14240 79706038
Skin fissures 49.73 15.24 37 24073 13036 79707242
Drug therapy 44.94 15.24 16 24094 1185 79719093
Respiratory tract infection 44.83 15.24 64 24046 48625 79671653
Endodontic procedure 44.50 15.24 20 24090 2723 79717555
Analgesic therapy 43.74 15.24 15 24095 994 79719284
Hyperhidrosis 43.45 15.24 122 23988 151370 79568908
Allergic sinusitis 41.96 15.24 14 24096 853 79719425
General physical health deterioration 41.51 15.24 179 23931 275059 79445219
CFTR gene mutation 41.12 15.24 9 24101 105 79720173
Constipation 41.11 15.24 182 23928 282868 79437410
Toothache 39.82 15.24 39 24071 19931 79700347
Sleep disorder therapy 39.68 15.24 14 24096 1010 79719268
Dry mouth 36.96 15.24 82 24028 87937 79632341
Flushing 36.80 15.24 82 24028 88186 79632092
Tooth disorder 35.96 15.24 42 24068 26191 79694087
Hyperphosphataemia 35.96 15.24 23 24087 6353 79713925
Exostosis 35.64 15.24 34 24076 16824 79703454
Sputum culture 35.00 15.24 9 24101 217 79720061
Discoloured vomit 34.68 15.24 14 24096 1464 79718814
Gastrointestinal disorder 34.62 15.24 98 24012 122107 79598171
Cystitis 34.18 15.24 59 24051 52673 79667605
Osteoarthritis 34.05 15.24 79 24031 87230 79633048
Sleep apnoea syndrome 33.65 15.24 48 24062 36430 79683848
Pyrexia 32.83 15.24 101 24009 678608 79041670
Localised infection 32.56 15.24 48 24062 37527 79682751
Skin lesion 31.39 15.24 50 24060 41794 79678484
Infusion related reaction 31.13 15.24 145 23965 230092 79490186
Sleep disorder 30.69 15.24 75 24035 85602 79634676
Fluid retention 30.39 15.24 66 24044 69743 79650535
Heart rate decreased 30.07 15.24 66 24044 70250 79650028
Dyspnoea 29.77 15.24 392 23718 856633 78863645
Blood potassium increased 29.21 15.24 40 24070 29235 79691043
Alopecia 28.96 15.24 17 24093 231338 79488940
Febrile neutropenia 27.49 15.24 18 24092 230981 79489297
Peripheral swelling 26.88 15.24 156 23954 269461 79450817
Drug abuse 26.69 15.24 8 24102 162683 79557595
Blood pressure decreased 26.46 15.24 78 24032 99388 79620890
Neutropenia 26.20 15.24 29 24081 287681 79432597
Rheumatoid arthritis 25.80 15.24 128 23982 208342 79511936
Tinnitus 25.39 15.24 47 24063 44286 79675992
Drug intolerance 25.16 15.24 151 23959 263968 79456310
Blood iron decreased 25.07 15.24 27 24083 15407 79704871
Wound 24.77 15.24 3 24107 116176 79604102
Hypophosphataemia 24.21 15.24 30 24080 19883 79700395
Skin discolouration 24.13 15.24 44 24066 40990 79679288
Synovitis 23.68 15.24 8 24102 150726 79569552
Dental caries 23.41 15.24 23 24087 11797 79708481
Lip pruritus 22.65 15.24 9 24101 903 79719375
Abdominal pain upper 22.63 15.24 130 23980 223689 79496589
Intentional overdose 21.95 15.24 3 24107 105957 79614321
Pancreatitis relapsing 21.88 15.24 9 24101 987 79719291
Thrombocytopenia 21.75 15.24 29 24081 265230 79455048
Interstitial lung disease 21.50 15.24 4 24106 112596 79607682
Hand deformity 21.39 15.24 3 24107 103916 79616362
Internal haemorrhage 20.96 15.24 19 24091 8814 79711464
Product use in unapproved indication 20.91 15.24 27 24083 250332 79469946
Therapeutic reaction time decreased 20.67 15.24 13 24097 3488 79716790
Mite allergy 20.05 15.24 9 24101 1221 79719057
Bone hypertrophy 19.02 15.24 7 24103 570 79719708
Myocardial infarction 18.64 15.24 107 24003 184022 79536256
Neuralgia 18.63 15.24 35 24075 33349 79686929
Fibromyalgia 18.60 15.24 52 24058 64288 79655990
Drug interaction 18.49 15.24 64 24046 415119 79305159
Blood pressure increased 18.34 15.24 118 23992 211242 79509036
White blood cell count decreased 18.23 15.24 18 24092 188270 79532008
Nephrogenic systemic fibrosis 18.16 15.24 15 24095 6145 79714133
Joint swelling 18.06 15.24 149 23961 288497 79431781
Anaphylactic reaction 17.98 15.24 61 24049 83682 79636596
Withdrawal hypertension 17.79 15.24 6 24104 378 79719900
Malaise 17.74 15.24 226 23884 489643 79230635
Medication error 17.47 15.24 53 24057 68589 79651689
Platelet count decreased 17.30 15.24 20 24090 194644 79525634
Migraine 16.44 15.24 61 24049 87432 79632846
Coma 16.41 15.24 5 24105 100644 79619634
Pulmonary function test abnormal 16.37 15.24 12 24098 4132 79716146
Haematochezia 15.56 15.24 60 24050 87585 79632693
Sinusitis 15.39 15.24 22 24088 195479 79524799
Cough 15.36 15.24 174 23936 366615 79353663

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC B03AA03 BLOOD AND BLOOD FORMING ORGANS
ANTIANEMIC PREPARATIONS
IRON PREPARATIONS
Iron bivalent, oral preparations
ATC B03AD05 BLOOD AND BLOOD FORMING ORGANS
ANTIANEMIC PREPARATIONS
IRON PREPARATIONS
Iron in combination with folic acid
FDA CS M0011718 Iron
MeSH PA D006397 Hematinics
MeSH PA D006401 Hematologic Agents
FDA EPC N0000177913 Parenteral Iron Replacement

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Anemia of prematurity indication 47100003 DOID:11243
Iron deficiency anemia indication 87522002
Peptic ulcer contraindication 13200003 DOID:750
Gastroenteritis contraindication 25374005 DOID:2326
Hemosiderosis contraindication 39011001 DOID:12119
Hemolytic anemia contraindication 61261009 DOID:583
Ulcerative colitis contraindication 64766004 DOID:8577
Diverticular disease contraindication 397881000
Hemochromatosis contraindication 399187006 DOID:2352
Repeated Blood Transfusions contraindication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D02394 KEGG_DRUG
4024159 VUID
N0000148626 NUI
34089-81-1 SECONDARY_CAS_RN
4017678 VANDF
4019180 VANDF
4021178 VANDF
4024159 VANDF
CHEBI:31608 CHEBI
CHEMBL3833303 ChEMBL_ID
CHEMBL3991443 ChEMBL_ID
CHEMBL1201494 ChEMBL_ID
C011819 MESH_SUPPLEMENTAL_RECORD_UI
DB14488 DRUGBANK_ID
U1B11I423Z UNII
DB09517 DRUGBANK_ID
24942 RXNORM
189358 MMSL
4724 MMSL
5409 MMSL
7975 MMSL
d03822 MMSL
d04387 MMSL
000834 NDDF
007777 NDDF
116130008 SNOMEDCT_US
26736008 SNOMEDCT_US
387147005 SNOMEDCT_US
786421005 SNOMEDCT_US
C0060277 UMLSCUI
23616740 PUBCHEM_CID
6047-12-7 SECONDARY_CAS_RN

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Ferrlecit HUMAN PRESCRIPTION DRUG LABEL 1 0024-2792 INJECTION 12.50 mg INTRAVENOUS NDA 25 sections
Ferrlecit HUMAN PRESCRIPTION DRUG LABEL 1 0024-2792 INJECTION 12.50 mg INTRAVENOUS NDA 25 sections
Ferrlecit HUMAN PRESCRIPTION DRUG LABEL 1 0024-2794 INJECTION 12.50 mg INTRAVENOUS NDA 26 sections
Ferrlecit HUMAN PRESCRIPTION DRUG LABEL 1 0024-2794 INJECTION 12.50 mg INTRAVENOUS NDA 26 sections
Sodium Ferric Gluconate Complex in Sucrose HUMAN PRESCRIPTION DRUG LABEL 1 0143-9298 INJECTION 12.50 mg INTRAVENOUS ANDA 24 sections
Sodium Ferric Gluconate Complex in Sucrose HUMAN PRESCRIPTION DRUG LABEL 1 0143-9298 INJECTION 12.50 mg INTRAVENOUS ANDA 24 sections
Sodium Ferric Gluconate Complex in Sucrose HUMAN PRESCRIPTION DRUG LABEL 1 0143-9570 INJECTION 12.50 mg INTRAVENOUS ANDA 24 sections
Sodium Ferric Gluconate Complex in Sucrose HUMAN PRESCRIPTION DRUG LABEL 1 0143-9570 INJECTION 12.50 mg INTRAVENOUS ANDA 24 sections
CitraNatal Bloom HUMAN PRESCRIPTION DRUG LABEL 6 0178-0813 TABLET, FILM COATED 13.20 mg ORAL unapproved drug other 15 sections
CitraNatal Bloom HUMAN PRESCRIPTION DRUG LABEL 6 0178-0813 TABLET, FILM COATED 13.20 mg ORAL unapproved drug other 15 sections
CitraNatal Bloom HUMAN PRESCRIPTION DRUG LABEL 6 0178-0813 TABLET, FILM COATED 13.20 mg ORAL unapproved drug other 15 sections
CitraNatal 90 DHA HUMAN PRESCRIPTION DRUG LABEL 16 0178-0821 TABLET 5 mg ORAL unapproved drug other 11 sections
CitraNatal 90 DHA HUMAN PRESCRIPTION DRUG LABEL 16 0178-0821 TABLET 5 mg ORAL unapproved drug other 11 sections
BioFerr 90 HUMAN PRESCRIPTION DRUG LABEL 6 44523-732 TABLET, FILM COATED 13.20 mg ORAL Unapproved drug other 20 sections